SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-22-003562
Filing Date
2022-03-14
Accepted
2022-03-14 16:51:26
Documents
5
Effectiveness Date
2022-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220314xs8.htm S-8 70674
2 EX-5.1 tmb-20220314xex5d1.htm EX-5.1 11976
3 EX-23.1 tmb-20220314xex23d1.htm EX-23.1 2283
4 EX-FILING FEES tmb-20220314xexfilingfees.htm EX-FILING FEES 25550
5 GRAPHIC tmb-20220314xex5d1001.jpg GRAPHIC 3158
  Complete submission text file 0001558370-22-003562.txt   116004
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263536 | Film No.: 22737281
SIC: 2834 Pharmaceutical Preparations